Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Mabwell Bioscience Extends Research Partnership with Fudan University Cancer Center

October 24, 2024
CompanyDrug

Hengrui Pharmaceuticals Scores First-Mover Status with FDA Approval for Generic Astagraf XL

December 3, 2024
CompanyDeals

Gilead Increases Stake in Arcus Biosciences and Invests in Anti-TIGIT Program

October 24, 2024
CompanyDrug

Takeda’s Gammagard Liquid Approved by FDA for Chronic Inflammatory Demyelinating Polyneuropathy

October 24, 2024
CompanyHospital

Shaanxi Province Unveils Ambitious Three-Year Plan to Boost Traditional Chinese Medicine Industry

October 24, 2024
CompanyDrug

AstraZeneca’s Enhertu Receives Priority Review for Expanded HER2-positive Solid Tumor Indication

October 24, 2024
Company

MicroPort Scientific Corp. Forecasts 31%-34% Revenue Growth for Subsidiary MicroPort Endovascular in 2023

October 24, 2024
CompanyDeals

SANDT Secures Nearly RMB 200 Million to Boost X-ray System Development and Manufacturing

October 24, 2024
CompanyDeals

Joincare Pharmaceutical Group Secures USD 100 Million Loan from IFC for Expansion

October 24, 2024
CompanyDeals

South Korean Duo GC Wellbeing and YooYoung Pharmaceutical Target Chinese Filler Market

October 24, 2024
CompanyDeals

TYK Medicines Files for IPO on HKSE Amid Rising Losses and Expanding Drug Pipeline

October 24, 2024
CompanyDrug

Bristol Myers Squibb’s Subcutaneous Opdivo Shows Noninferiority in Phase III ccRCC Trial

November 13, 2024
1 2 3 4 … 27 28
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up